SC H4262

Prohibits healthcare professionals in South Carolina from administering synthetic mRNA-based gene therapy products intended to prevent or mitigate transmission of communicable diseases (such as COVID-19 vaccines)

Defines covered products as those using synthetic mRNA technology, modified mRNA with pseudouridine, or self-amplifying mRNA technology that deliver foreign genetic material into human cells

Exempts mRNA therapies for treating non-infectious diseases like cancer or rare genetic conditions, as well as traditional live attenuated vaccines and FDA-authorized recombinant vaccines

Requires mandatory license suspension of at least one year for healthcare professionals who intentionally or willfully violate the prohibition, with licensing boards authorized to impose additional penalties

Mandates professional licensing boards to report all violations to the Department of Public Health, which must maintain records for seven years and provide annual reports to the General Assembly